Awarded

Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Peginterferon beta-1a, ATC L03AB13 für die Zeit 01.05.2025 - 30.04.2027

Name: Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Peginterferon beta-1a, ATC L03AB13 für die Zeit 01.05.2025 - 30.04.2027
Creator: DAK-Gesundheit
Published: 2026-01-12
License: https://ted.europa.eu/en/simap/legal-notice

Buyer: DAK-Gesundheit
Winners: CC Pharma GmbH, EurimPharm Arzneimittel GmbH, Orifarm GmbH, Originalis B.V.
Contract value: no value published
Bids received: 4
Published: 12 Jan 2026
Awarded: 1 May 2025
Contract start: 1 May 2025
Sector: Medical equipment and pharmaceuticals
Region: Hamburg (DE600)
Source: Original notice on TED (19342-2026)

More awards from this buyer

Awarded	Buyer	Winner	Contract value	Published
356 - BARMER - Mometason - R01AD09	DAK-Gesundheit	BG ALIUD / STADAPHARM GbR, BG Hexal 1A Pharma GbR, BG TEVA ratiopharm GbR	—	6 Aug 2026
355 - BARMER - Bupropion - N06AX12	DAK-Gesundheit	Accord Healthcare GmbH, Basics GmbH, BG Hexal 1A Pharma GbR	—	6 Aug 2026
354 - BARMER - Escitalopram - N06AB10 (FTA / SMT)	DAK-Gesundheit	BG Hexal 1A Pharma GbR, Micro Labs GmbH, PUREN Pharma GmbH & Co. KG	—	6 Aug 2026
353 - BARMER - Levetiracetam - N03AX14 (FTA)	DAK-Gesundheit	Accord Healthcare S.L.U. vertreten durch Accord Healthcare GmbH, betapharm Arzneimittel GmbH, PUREN Pharma GmbH & Co. KG	—	6 Aug 2026
352 - BARMER - Fentanyl - N02AB03 (PFT)	DAK-Gesundheit	BG ALIUD / STADAPHARM GbR, BG Hennig/Viatris/Puren GbR, BG Zentiva/Hexal/Aristo GbR	—	6 Aug 2026
351 - BARMER - Morphin - N02AA01 (Oral retardiert)	DAK-Gesundheit	BG ALIUD / STADAPHARM GbR, BG Heumann / G.L. Pharma GbR, BG TEVA ratiopharm GbR	—	6 Aug 2026